[Form 4] ANEW MEDICAL, INC. Common Stock Insider Trading Activity
Form 4 filing for Klotho Neurosciences, Inc. (KLTO) by Joseph Sinkule, CEO and Director. The filing reports two transactions: on 07/22/2025 and 08/05/2025 the Reporting Person transferred and pledged a total of 2,000,000 common shares to Stock Loan Solutions, LLC as collateral for a non-recourse, 3-year term loan. The lender may take actions with respect to the pledged shares, including selling, transferring, hedging, or creating and trading derivatives.
The report shows 4,446,700 shares beneficially owned following the 08/05/2025 transaction, which includes 1,000,000 shares issuable on incentive option exercise and 537,180 shares received as contingent merger consideration. The Reporting Person retains a conditional right to vote the pledged shares absent default; lender must transfer shares back within five business days of repayment, subject to setoff rights.
Segnalazione Form 4 per Klotho Neurosciences, Inc. (KLTO) da parte di Joseph Sinkule, CEO e membro del consiglio di amministrazione. La segnalazione riporta due operazioni: il 07/22/2025 e il 08/05/2025 la persona dichiarante ha trasferito e dato in pegno un totale di 2,000,000 azioni ordinarie a Stock Loan Solutions, LLC come garanzia per un prestito a termine di 3 anni senza ricorso. Il creditore può compiere azioni sulle azioni date in garanzia, inclusa la vendita, il trasferimento, l'hedging o la creazione e negoziazione di derivati.
La relazione indica 4,446,700 azioni possedute beneficiariamente a seguito della transazione del 08/05/2025, che comprendono 1,000,000 azioni emettibili al momento dell'esercizio di opzioni incentivanti e 537,180 azioni ricevute come corrispettivo condizionato per una fusione. La persona dichiarante conserva un diritto condizionato di voto sulle azioni in pegno in assenza di inadempienza; il prestatore deve restituire le azioni entro cinque giorni lavorativi dal rimborso, fatto salvo il diritto di compensazione.
Presentación del Formulario 4 para Klotho Neurosciences, Inc. (KLTO) por Joseph Sinkule, CEO y miembro del consejo. El informe registra dos transacciones: el 07/22/2025 y el 08/05/2025 la persona informante transfirió y prendó un total de 2,000,000 acciones comunes a Stock Loan Solutions, LLC como garantía de un préstamo a plazo de 3 años sin recurso. El prestamista puede tomar medidas respecto a las acciones pignoradas, incluyendo vender, transferir, cubrir posiciones (hedging) o crear y negociar derivados.
El informe muestra 4,446,700 acciones poseídas de forma beneficiaria tras la transacción del 08/05/2025, que incluyen 1,000,000 acciones exigibles al ejercer opciones incentivas y 537,180 acciones recibidas como contraprestación condicional por fusión. La persona informante conserva un derecho condicional de voto sobre las acciones pignoradas mientras no haya incumplimiento; el prestamista debe devolver las acciones en un plazo de cinco días hábiles tras el reembolso, sujeto a derechos de compensación.
Klotho Neurosciences, Inc. (KLTO)에 대한 Joseph Sinkule(CEO 겸 이사)의 Form 4 제출. 제출서류는 두 건의 거래를 보고합니다: 07/22/2025 및 08/05/2025에 보고인은 담보로 총 2,000,000 보통주를 Stock Loan Solutions, LLC에 양도·담보제공했으며, 이는 무소구(non-recourse) 3년 만기 대출의 담보입니다. 대출기관은 담보주식에 대해 매각, 이전, 헤지 또는 파생상품의 생성·거래 등 조치를 취할 수 있습니다.
보고서는 08/05/2025 거래 이후 실질적으로 보유한 4,446,700주를 기록하고 있으며, 여기에는 인센티브 옵션 행사로 발생하는 1,000,000주와 합병의 조건부 대가로 받은 537,180주가 포함됩니다. 보고인은 채무불이행이 없는 한 담보주식에 대해 조건부 의결권을 유지하며, 대출자는 상환 후 5영업일 이내에 주식을 반환해야 하되 상계권은 적용될 수 있습니다.
Dépôt du Formulaire 4 pour Klotho Neurosciences, Inc. (KLTO) par Joseph Sinkule, PDG et administrateur. Le document rapporte deux opérations : le 07/22/2025 et le 08/05/2025, la personne déclarante a transféré et mis en nantissement un total de 2,000,000 actions ordinaires auprès de Stock Loan Solutions, LLC en garantie d'un prêt à terme de 3 ans sans recours. Le prêteur peut agir sur les actions nanties, notamment vendre, transférer, couvrir (hedging) ou créer et négocier des dérivés.
Le rapport indique 4,446,700 actions détenues à titre bénéficiaire après la transaction du 08/05/2025, comprenant 1,000,000 actions susceptibles d'être émises à l'exercice d'options incitatives et 537,180 actions reçues comme contrepartie conditionnelle de fusion. La personne déclarante conserve un droit conditionnel de vote sur les actions nanties en l'absence de défaut ; le prêteur doit restituer les actions dans les cinq jours ouvrables suivant le remboursement, sous réserve d'un droit de compensation.
Form 4-Einreichung für Klotho Neurosciences, Inc. (KLTO) durch Joseph Sinkule, CEO und Director. Die Meldung berichtet über zwei Transaktionen: am 07/22/2025 und am 08/05/2025 hat die meldepflichtige Person insgesamt 2,000,000 Stammaktien an Stock Loan Solutions, LLC übertragen und verpfändet als Sicherheit für einen nicht rückgriffsfähigen, 3-jährigen Terminkredit. Der Kreditgeber kann Maßnahmen an den verpfändeten Aktien vornehmen, einschließlich Verkauf, Übertragung, Absicherung (Hedging) oder Schaffung und Handel mit Derivaten.
Der Bericht weist 4,446,700 wirtschaftlich gehaltene Aktien nach der Transaktion vom 08/05/2025 aus, zu denen 1,000,000 Aktien, die bei Ausübung von Incentive-Optionen ausgegeben werden können, und 537,180 Aktien, die als bedingte Fusionsvergütung erhalten wurden, gehören. Die meldepflichtige Person behält ein bedingtes Stimmrecht an den verpfändeten Aktien, sofern kein Default eintritt; der Kreditgeber muss die Aktien binnen fünf Geschäftstagen nach Rückzahlung zurückübertragen, vorbehaltlich von Aufrechnungsrechten.
- Reporting Person retains conditional voting rights over pledged shares absent default
- Loan term explicitly stated as 3 years, providing a defined collateral timeline
- Beneficial ownership after transactions: 4,446,700 shares (explicitly disclosed)
- 2,000,000 shares pledged as collateral to Stock Loan Solutions, LLC for a non-recourse loan
- Lender may sell, assign, transfer, pledge, hypothecate, lend, hedge, or create derivatives with the pledged shares
- Lender may be deemed beneficial owner of pledged shares during the loan term and has setoff rights on repayment
- Proceeds intended to liquidate personal obligations, indicating insider liquidity use
Insights
TL;DR: CEO pledged 2.0M shares as collateral for a non-recourse 3-year loan; lender has broad disposition and hedging rights.
The pledge of 2,000,000 common shares by the CEO and Director is a material change in ownership structure reported on Form 4. The filing explicitly states the lender may sell, assign, transfer, pledge, hypothecate, lend, encumber, enter hedging arrangements, or create and trade derivative instruments backed by the shares. This creates potential near-term supply overhang risk and may affect market perception of insider liquidity needs, since proceeds are intended to liquidate personal obligations. The inclusion of 1,000,000 option-issuable shares in beneficial ownership and 537,180 contingent merger consideration should be tracked when modeling outstanding share count and dilution. Overall impact: negative due to pledge and lender rights.
TL;DR: Pledge grants lender broad rights and potential deemed beneficial ownership; conditional voting retained absent default.
From a governance and counterparty-risk perspective, the filing documents a non-recourse, 3-year loan secured by pledged shares and notes the lender may be deemed the beneficial owner during the loan term. The Reporting Person retains conditional voting rights absent default, and the lender must transfer shares back within five business days of repayment subject to setoff. These contractual mechanics raise counterparty and market-risk considerations: the lender's right to transfer or hedge the shares is explicit, and setoff rights could delay repatriation of shares. The disclosure signals increased insider leverage and is material and negative for shareholder dilution and governance monitoring.
Segnalazione Form 4 per Klotho Neurosciences, Inc. (KLTO) da parte di Joseph Sinkule, CEO e membro del consiglio di amministrazione. La segnalazione riporta due operazioni: il 07/22/2025 e il 08/05/2025 la persona dichiarante ha trasferito e dato in pegno un totale di 2,000,000 azioni ordinarie a Stock Loan Solutions, LLC come garanzia per un prestito a termine di 3 anni senza ricorso. Il creditore può compiere azioni sulle azioni date in garanzia, inclusa la vendita, il trasferimento, l'hedging o la creazione e negoziazione di derivati.
La relazione indica 4,446,700 azioni possedute beneficiariamente a seguito della transazione del 08/05/2025, che comprendono 1,000,000 azioni emettibili al momento dell'esercizio di opzioni incentivanti e 537,180 azioni ricevute come corrispettivo condizionato per una fusione. La persona dichiarante conserva un diritto condizionato di voto sulle azioni in pegno in assenza di inadempienza; il prestatore deve restituire le azioni entro cinque giorni lavorativi dal rimborso, fatto salvo il diritto di compensazione.
Presentación del Formulario 4 para Klotho Neurosciences, Inc. (KLTO) por Joseph Sinkule, CEO y miembro del consejo. El informe registra dos transacciones: el 07/22/2025 y el 08/05/2025 la persona informante transfirió y prendó un total de 2,000,000 acciones comunes a Stock Loan Solutions, LLC como garantía de un préstamo a plazo de 3 años sin recurso. El prestamista puede tomar medidas respecto a las acciones pignoradas, incluyendo vender, transferir, cubrir posiciones (hedging) o crear y negociar derivados.
El informe muestra 4,446,700 acciones poseídas de forma beneficiaria tras la transacción del 08/05/2025, que incluyen 1,000,000 acciones exigibles al ejercer opciones incentivas y 537,180 acciones recibidas como contraprestación condicional por fusión. La persona informante conserva un derecho condicional de voto sobre las acciones pignoradas mientras no haya incumplimiento; el prestamista debe devolver las acciones en un plazo de cinco días hábiles tras el reembolso, sujeto a derechos de compensación.
Klotho Neurosciences, Inc. (KLTO)에 대한 Joseph Sinkule(CEO 겸 이사)의 Form 4 제출. 제출서류는 두 건의 거래를 보고합니다: 07/22/2025 및 08/05/2025에 보고인은 담보로 총 2,000,000 보통주를 Stock Loan Solutions, LLC에 양도·담보제공했으며, 이는 무소구(non-recourse) 3년 만기 대출의 담보입니다. 대출기관은 담보주식에 대해 매각, 이전, 헤지 또는 파생상품의 생성·거래 등 조치를 취할 수 있습니다.
보고서는 08/05/2025 거래 이후 실질적으로 보유한 4,446,700주를 기록하고 있으며, 여기에는 인센티브 옵션 행사로 발생하는 1,000,000주와 합병의 조건부 대가로 받은 537,180주가 포함됩니다. 보고인은 채무불이행이 없는 한 담보주식에 대해 조건부 의결권을 유지하며, 대출자는 상환 후 5영업일 이내에 주식을 반환해야 하되 상계권은 적용될 수 있습니다.
Dépôt du Formulaire 4 pour Klotho Neurosciences, Inc. (KLTO) par Joseph Sinkule, PDG et administrateur. Le document rapporte deux opérations : le 07/22/2025 et le 08/05/2025, la personne déclarante a transféré et mis en nantissement un total de 2,000,000 actions ordinaires auprès de Stock Loan Solutions, LLC en garantie d'un prêt à terme de 3 ans sans recours. Le prêteur peut agir sur les actions nanties, notamment vendre, transférer, couvrir (hedging) ou créer et négocier des dérivés.
Le rapport indique 4,446,700 actions détenues à titre bénéficiaire après la transaction du 08/05/2025, comprenant 1,000,000 actions susceptibles d'être émises à l'exercice d'options incitatives et 537,180 actions reçues comme contrepartie conditionnelle de fusion. La personne déclarante conserve un droit conditionnel de vote sur les actions nanties en l'absence de défaut ; le prêteur doit restituer les actions dans les cinq jours ouvrables suivant le remboursement, sous réserve d'un droit de compensation.
Form 4-Einreichung für Klotho Neurosciences, Inc. (KLTO) durch Joseph Sinkule, CEO und Director. Die Meldung berichtet über zwei Transaktionen: am 07/22/2025 und am 08/05/2025 hat die meldepflichtige Person insgesamt 2,000,000 Stammaktien an Stock Loan Solutions, LLC übertragen und verpfändet als Sicherheit für einen nicht rückgriffsfähigen, 3-jährigen Terminkredit. Der Kreditgeber kann Maßnahmen an den verpfändeten Aktien vornehmen, einschließlich Verkauf, Übertragung, Absicherung (Hedging) oder Schaffung und Handel mit Derivaten.
Der Bericht weist 4,446,700 wirtschaftlich gehaltene Aktien nach der Transaktion vom 08/05/2025 aus, zu denen 1,000,000 Aktien, die bei Ausübung von Incentive-Optionen ausgegeben werden können, und 537,180 Aktien, die als bedingte Fusionsvergütung erhalten wurden, gehören. Die meldepflichtige Person behält ein bedingtes Stimmrecht an den verpfändeten Aktien, sofern kein Default eintritt; der Kreditgeber muss die Aktien binnen fünf Geschäftstagen nach Rückzahlung zurückübertragen, vorbehaltlich von Aufrechnungsrechten.
FAQ
What did Joseph Sinkule (CEO) report on this KLTO Form 4?
How many shares does the reporting person beneficially own after the transactions?
Can the lender trade or sell the pledged KLTO shares?
What are the lender's transfer and setoff rights on repayment?
Why did the Reporting Person take the loan proceeds?
